Vivus' potential weight loss drug Qnexa will likely draw scrutiny over nervous system and psychiatric side effects from a panel of Food and Drug Administration experts this week.
The FDA acknowledges the potential blockbuster drug's effectiveness in cutting weight. But, in briefing documents the agency raises concerns about a range of side effects. …
Комментариев нет:
Отправить комментарий